DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2025. âOur second quarter results reflect strong execution of our strategic 2025 priorities, with sequential and year-over-year growth in revenue and Adjusted EBITDA,â said Barb Jacobsmeyer, president and CEO of Enhabit. âHome health continued to benefit from our payer contract initiatives as admissions grew 1.3% yea
Related Questions
What were the specific revenue growth percentages versus prior quarters and yearâoverâyear?
Did Enhabit provide guidance or outlook for Q3 and fullâyear 2025 earnings and Adjusted EBITDA?
Did the company disclose any capex or capital allocation plans that might influence future earnings?
How does Enhabit's current valuation metrics (e.g., P/E, EV/EBITDA) compare to its major competitors?
Are there any risks highlighted in the call or filing that could affect the company's forwardâlooking performance?
What is the market's reaction to the earnings release in terms of price movement and volume?
How does the reported Adjusted EBITDA margin compare to the company's historical range and peers in home health and hospice?
What is the impact of the payer contract initiatives on future admission growth and profitability?
How does the 1.3% yearâoverâyear admissions growth in home health compare to the industry average?
Are there any notable changes in operating expenses, such as staffing or overhead, that could affect cash flow?